Clearance Summary
Ki Mobility Focus CR, Ki Mobility Focus CRe, Ki Mobility Focus CR TTL received FDA 510(k) clearance under submission number K200583, sponsored by Ki Mobility, LLC. The device was reviewed via the Traditional premarket notification pathway and assigned to the Physical Medicine review panel. The statutory decision date of record is 2023-09-05.
- Submission: K200583
- Applicant / Sponsor: Ki Mobility, LLC
- Clearance pathway: Traditional
- Review panel: Physical Medicine
- Device class: Class I
- Regulation citation: 21 CFR 890.3850
- Decision date: 2023-09-05
Classification & Regulation
This clearance is catalogued under FDA product code IOR and 21 CFR 890.3850, within the Physical Medicine review panel as a Class I device.